O
MRTX

OrbiMed’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,959,050
Closed -$85.3M 133
2023
Q3
$85.3M Buy
1,959,050
+1,045,400
+114% +$45.5M 1.81% 15
2023
Q2
$33M Hold
913,650
0.6% 54
2023
Q1
$34M Sell
913,650
-370,042
-29% -$13.8M 0.67% 48
2022
Q4
$58.2M Sell
1,283,692
-135,200
-10% -$6.13M 1.11% 34
2022
Q3
$99.1K Buy
1,418,892
+328,492
+30% +$22.9K 1.84% 18
2022
Q2
$73.2K Sell
1,090,400
-540,100
-33% -$36.3K 1.33% 27
2022
Q1
$134M Buy
1,630,500
+204,100
+14% +$16.8M 2.17% 14
2021
Q4
$209M Buy
1,426,400
+53,200
+4% +$7.8M 2.69% 7
2021
Q3
$243M Buy
1,373,200
+109,000
+9% +$19.3M 2.67% 8
2021
Q2
$204M Buy
1,264,200
+43,000
+4% +$6.95M 2.07% 13
2021
Q1
$209M Buy
1,221,200
+75,900
+7% +$13M 1.96% 16
2020
Q4
$252M Sell
1,145,300
-171,700
-13% -$37.7M 2.2% 9
2020
Q3
$219M Sell
1,317,000
-7,100
-0.5% -$1.18M 2.75% 8
2020
Q2
$151M Sell
1,324,100
-99,200
-7% -$11.3M 2.13% 16
2020
Q1
$109M Buy
1,423,300
+82,700
+6% +$6.36M 1.84% 17
2019
Q4
$173M Buy
1,340,600
+805,457
+151% +$104M 2.47% 10
2019
Q3
$41.7M Buy
+535,143
New +$41.7M 0.79% 41
2016
Q2
Sell
-197,859
Closed -$4.23M 141
2016
Q1
$4.23M Buy
197,859
+165,659
+514% +$3.54M 0.04% 119
2015
Q4
$1.02M Sell
32,200
-207,800
-87% -$6.57M 0.01% 124
2015
Q3
$8.26M Sell
240,000
-440,500
-65% -$15.2M 0.08% 97
2015
Q2
$21.4M Sell
680,500
-586,500
-46% -$18.5M 0.18% 80
2015
Q1
$37.1M Buy
1,267,000
+100,000
+9% +$2.93M 0.32% 59
2014
Q4
$21.6M Hold
1,167,000
0.21% 69
2014
Q3
$20.4M Sell
1,167,000
-5,000
-0.4% -$87.5K 0.21% 70
2014
Q2
$23.4M Sell
1,172,000
-102,332
-8% -$2.05M 0.28% 57
2014
Q1
$24.3M Hold
1,274,332
0.3% 56
2013
Q4
$21.2M Buy
1,274,332
+125,000
+11% +$2.08M 0.31% 60
2013
Q3
$17.4M Buy
+1,149,332
New +$17.4M 0.31% 57